Clinical Trial Update: Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial is recruiting to evaluate Adebrelimab in combination with chemotherapy and concurrent SBRT as neoadjuvant treatment for limited-stage small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer | Phase 2 | Status: RECRUITING